Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 11
2015 9
2016 8
2017 7
2018 15
2019 9
2020 15
2021 21
2022 15
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Lung Cancer in Italy.
Passiglia F, Calandri M, Guerrera F, Malapelle U, Mangone L, Ramella S, Trisolini R, Novello S. Passiglia F, et al. J Thorac Oncol. 2019 Dec;14(12):2046-2052. doi: 10.1016/j.jtho.2019.05.019. J Thorac Oncol. 2019. PMID: 31757374 Free article. No abstract available.
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality.
Farinea G, Crespi V, Listì A, Righi L, Bironzo P, Merlini A, Malapelle U, Novello S, Scagliotti GV, Passiglia F. Farinea G, et al. Among authors: passiglia f. J Thorac Oncol. 2023 Sep;18(9):1146-1164. doi: 10.1016/j.jtho.2023.05.028. Epub 2023 Jun 16. J Thorac Oncol. 2023. PMID: 37331604 Free article. Review.
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Anobile DP, Salaroglio IC, Tabbò F, La Vecchia S, Akman M, Napoli F, Bungaro M, Benso F, Aldieri E, Bironzo P, Kopecka J, Passiglia F, Righi L, Novello S, Scagliotti GV, Riganti C. Anobile DP, et al. Among authors: passiglia f. Clin Cancer Res. 2023 Oct 2;29(19):3958-3973. doi: 10.1158/1078-0432.CCR-22-3949. Clin Cancer Res. 2023. PMID: 37285115
Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study.
Zhang K, Zhou C, Gao J, Yu P, Lin X, Xie X, Liu M, Zhang J, Xie Z, Cui F, Li S, Passiglia F, Stella GM, Qin Y. Zhang K, et al. Among authors: passiglia f. Transl Lung Cancer Res. 2022 Nov;11(11):2306-2317. doi: 10.21037/tlcr-22-667. Transl Lung Cancer Res. 2022. PMID: 36519030 Free PMC article.
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer.
Listì A, Barraco N, Bono M, Insalaco L, Castellana L, Cutaia S, Ricciardi MR, Gristina V, Bronte E, Pantuso G, Passiglia F. Listì A, et al. Among authors: passiglia f. Transl Cancer Res. 2019 Jan;8(Suppl 1):S55-S63. doi: 10.21037/tcr.2018.10.04. Transl Cancer Res. 2019. PMID: 35117064 Free PMC article. Review.
Repositioning PARP inhibitors in the treatment of thoracic malignancies.
Passiglia F, Reale ML, Cetoretta V, Parlagreco E, Jacobs F, Listì A, Righi L, Bironzo P, Novello S, Scagliotti GV. Passiglia F, et al. Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7. Cancer Treat Rev. 2021. PMID: 34261032 Review.
115 results